CorMedix Inc expected to post a loss of 20 cents a share - Earnings Preview

CorMedix

09/05/2023 03:02

* CorMedix Inc  CRMD.OQ   CRMD.O  is expected to report
results on
May 10 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for CorMedix Inc is for
a
loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CorMedix
Inc is
$16​, above​ its last closing price of $5.25. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022              -0.19      -0.20     Missed  -7
 Sep. 30 2022  -0.22       -0.23      -0.17     Beat    25.5
 Jun. 30 2022  -0.20       -0.21      -0.19     Beat    8.1​
 Mar. 31 2022  -0.22       -0.22      -0.18     Beat    18.2
 ​​Dec.                    -0.23      -0.20     Beat    14.3
 31 2021                                                
 Sep. 30 2021  -0.17       -0.18      -0.22     Missed  -24.5​
 Jun. 30 2021  -0.19       -0.17      -0.12     Beat    30.4
 Mar. 31 2021  -0.18       -0.18      -0.20     Missed  -8.7
 This summary was machine generated May 9 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated